arginyl-glycyl-aspartic acid has been researched along with salinomycin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Gao, J; Gong, Z; Li, B; Li, W; Liu, J; Lu, Y; Mao, X; Sun, Z; Yu, Y; Zhang, H; Zhong, Y; Zou, H | 1 |
1 other study(ies) available for arginyl-glycyl-aspartic acid and salinomycin
Article | Year |
---|---|
iRGD-conjugated DSPE-PEG2000 nanomicelles for targeted delivery of salinomycin for treatment of both liver cancer cells and cancer stem cells.
Topics: AC133 Antigen; Animals; Antigens, CD; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Gene Expression Regulation, Neoplastic; Glycoproteins; Hep G2 Cells; Humans; Liposomes; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Nanomedicine; Neoplasm Metastasis; Neoplasm Transplantation; Neoplastic Stem Cells; Neuropilin-1; Oligopeptides; Peptides; Phosphatidylethanolamines; Polyethylene Glycols; Pyrans; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2015 |